Supports collaborative research to map neural ensembles responding to addictive substances and build a multimodal database linking their activity to substance use behaviors; clinical trials are not allowed.
The NIDA Animal Genomics Program aims to identify genetic variants influencing addictive behaviors, SUD stages, associated behaviors, and comorbidities through genomics approaches.
NIH supports exploratory, phased clinical research on the neurobiological mechanisms of substance use disorders, including relevant circuitry and behavior; clinical trials are optional.
NIAAA plans to fund two research groups studying how brain and body dysregulation leads to excessive drinking and AUD, using advanced tools and collaborative approaches.
This grant supports early stage investigators proposing innovative, high-risk research on the biological and behavioral mechanisms underlying substance use disorders.
NIH supports discovery of in vivo chemical probes for novel brain targets, with applicants expected to have validated starting compounds and bioassays; clinical trials are not allowed.